genXone S.A. (WSE:GX1)
Poland · Delayed Price · Currency is PLN 5.30
-0.06 (-1.12%)
At close: Sep 18, 2026
genXone Market Cap
genXone has a market cap or net worth of 17.52 million as of September 18, 2026. Its market cap has decreased by -2.93% in one year.
Market Cap
17.52M
Enterprise Value
14.66M
Revenue
2.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.30
ChartMarket Cap Chart
Since September 4, 2020, genXone's market cap has decreased from 141.69M to 17.52M, a decrease of -87.64%. That is a compound annual growth rate of -29.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 17.52M | 32.83% |
| Dec 30, 2025 | 13.19M | -35.65% |
| Dec 30, 2024 | 20.49M | 15.53% |
| Dec 29, 2023 | 17.74M | -47.33% |
| Dec 30, 2022 | 33.67M | -51.33% |
| Dec 30, 2021 | 69.20M | 0.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.46B |
| NEUCA | 3.50B |
| Synektik Spólka Akcyjna | 3.01B |
| Voxel | 1.45B |
| Sygnis | 33.28M |
| Airway Medix | 30.04M |
| Nestmedic | 27.66M |
| Medicofarma Biotech | 25.56M |